- Home
- TGTX
TGTX
TG Therapeutics Inc.
as 01-17-2025 4:00pm EST
| Founded: | 1993 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | 1995 |
| Target Price: | $40.67 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.84 - $36.84 | Next Earning Date: | 02-26-2025 |
| Revenue: | $264,790,000 | Revenue Growth: | 39.53% |
| Revenue Growth (this year): | 43.7% | Revenue Growth (next year): | 66.91% |
Stock Insider Trading Activity of TG Therapeutics Inc. (TGTX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Power Sean A | TGTX | CFO | Jan 3 '25 | Sell | $29.41 | 21,358 | $629,382.29 | 670,632 | |
| Charney Laurence N | TGTX | Director | Nov 11 '24 | Sell | $30.20 | 25,000 | $754,875.00 | 212,479 | |
| Lonial Sagar | TGTX | Director | Nov 11 '24 | Sell | $30.44 | 5,000 | $152,200.00 | 100,195 | |
| Echelard Yann | TGTX | Director | Nov 5 '24 | Sell | $24.48 | 20,000 | $489,600.00 | 224,098 |
Latest TG Therapeutics Inc. News
TGTX Breaking Stock News: Dive into TGTX Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Exploring Three High Growth Tech Stocks In The United States
Insider Monkey
3 days ago
Is TG Therapeutics Inc. (TGTX) Among Tuesday’s Top Gainers?
Zacks
3 days ago
TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise
Zacks
3 days ago
TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?
Argus Research
4 days ago
TGTX: Raising target price to $31.00
Insider Monkey
4 days ago
Why TGTX Stock Is Rallying Today
MT Newswires
4 days ago
TG Therapeutics Provides Q4 Briumvi Revenue Guidance; Sets 2025 Total Revenue Outlook; Shares Rise Pre-Bell
GlobeNewswire
4 days ago
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones
Compare TGTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TGTX TG Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.